日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease.

对人类和 3D 细胞模型进行整合通路分析,确定 p38 MAPK-MK2 轴是阿尔茨海默病的一种治疗靶点

Naderi Yeganeh Pourya, Kwak Sang Su, Jorfi Mehdi, Koler Katjuša, Kalatturu Thejesh, von Maydell Djuna, Liu Zhiqing, Guo Kevin, Choi Younjung, Park Joseph, Abarca Nelson, Bakiasi Grisilda, Cetinbas Murat, Sadreyev Ruslan, Griciuc Ana, Quinti Luisa, Choi Se Hoon, Xia Weiming, Tanzi Rudolph E, Hide Winston, Kim Doo Yeon

Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice

基于表达的筛选鉴定出一种嗜小胶质细胞的AAV衣壳,可用于小鼠的直接给药和脑脊液给药。

Santoscoy, Miguel C; Espinoza, Paula; Hanlon, Killian S; Yang, Luna; Nieland, Lisa; Ng, Carrie; Badr, Christian E; Hickman, Suzanne; de la Cruz, Demitri; Griciuc, Ana; Elkhoury, Joseph; Bennett, Rachel E; Shen, Shiqian; Maguire, Casey A

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease

评估布美他尼作为阿尔茨海默病潜在治疗药物的疗效

Boyarko, Ben; Podvin, Sonia; Greenberg, Barry; Momper, Jeremiah D; Huang, Yadong; Gerwick, William H; Bang, Anne G; Quinti, Luisa; Griciuc, Ana; Kim, Doo Yeon; Tanzi, Rudolph E; Feldman, Howard H; Hook, Vivian

The role of innate immune genes in Alzheimer's disease

先天免疫基因在阿尔茨海默病中的作用

Griciuc, Ana; Tanzi, Rudolph E